Previous
Pause
Next
Skip to Navigation
↓
Publications
Year
Year
Year
-Year
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Researcher
- Any -
cristinapozo
usuario_prueba
Almeida e Silva, Filomena Augusta
Amorín , Ricardo
Angás Pajas, Jorge
Arenal , Raúl
Baptista , Pedro Miguel
Bernechea Navarro, María
Bover Arbós, Pere
Calvo Lacosta, Jorge Hugo
Carstensen , Hans-Heinrich
Castro Barrigón, Alberto
Cazcarro Castellano, Ignacio
Cobarrubias Baglietto, Sebastián Felipe
DeMiguel , Daniel
Espina Cadena, Laura
Fernandez Antoran, David
Ferrio Díaz, Juan Pedro
Gil Hernández, Vanesa
Gracia Lostao, Ana Isabel
Gurauskis , Jonas
Hernández Ainsa, Silvia
Hernández Latas, José Antonio
Hurtado Guerrero, Ramón
Jiménez Schuhmacher, Alberto
Juarez-Perez , Emilio J.
Köhler , Ralf
Martínez-Padilla , Jesús
Millán Gasca, Javier
Montiel , Manuel
Muñoz Soro, José Félix
Olmo , Jose
Ordovás Vidal, Laura
Philippidis , George
Ramón García, Santiago
Roque , Carla
Schoorlemmer , Jon
Sola , Daniel
Stavridis , Stelios
Sánchez Martínez, Diego
Velasco Lozano, Susana
Íñiguez Dieste, David
Title
Title
Year
Genetic KCa3.1-deficiency produces locomotor hyperactivity and alterations in cerebral monoamine levels.
2012
Activation of endothelial and epithelial KCa2.3 calcium-activated potassium channels by NS309 relaxes human small pulmonary arteries and bronchioles.
2012
Heavy metal to lower the pressure?
2012
Nitric Oxide: Orchestrator of Endothelium-Dependent Responses.
2012
Alterations of N-3 Polyunsaturated Fatty Acid-Activated K2P Channels in Hypoxia-Induced Pulmonary Hypertension.
2013
The potassium channel KCa3.1 as new therapeutic target for preventing obliterative airway disease after lung transplantation.
2013
Endothelial Small- and Intermediate-Conductance KCa Channels: An Update on Their Pharmacology and Usefulness as Cardiovascular Targets.
2013
Novel phenolic inhibitors of small/intermediate-conductance Ca2+-activated K+ channels, KCa3.1 and KCa2.3.
2013
Activation of KCa 3.1 by SKA-31 induces arteriolar dilation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.
2013
Preserved regulation of renal perfusion pressure by small and intermediate conductance KCa channels in hypertensive mice with or without renal failure.
2014
Expression of T-cell KV1.3 potassium channel correlates with pro-inflammatory cytokines and disease activity in ulcerative colitis.
2014
New Positive KCa Channel Gating Modulators with Selectivity for KCa3.1.
2014
Positive feedback regulation of agonist-stimulated endothelial Ca2+ dynamics by KCa3.1 channels in mouse mesenteric arteries.
2014
Modulation of KCa3.1 Channels by Eicosanoids, Omega-3 Fatty Acids, and Molecular Determinants.
2014
K+ -channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
2014
Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm.
2014
Pulmonary Hypertension in Wild Type Mice and Animals with Genetic Deficit in KCa2.3 and KCa3.1 Channels.
2014
A Novel Pan-negative-gating Modulator of KCa2/3 Channels, the Fluoro-di-benzoate, RA-2, Inhibits EDH-type Relaxation in Coronary Artery and Produces Bradycardia In Vivo.
2014
Survival protein anoctamin-6 controls multiple platelet responses including phospholipid scrambling, swelling, and protein cleavage.
2015
Tungstate-Targeting of BKαβ1 Channels Tunes ERK Phosphorylation and Cell Proliferation in Human Vascular Smooth Muscle.
2015
Pages
1
2
siguiente ›
última »